title: Perturbation of phospholipid and triacylglycerol fatty acid positional location in the heart of rats depleted of n-3 long-chain polyunsaturates.
abstract: Rats depleted of long-chain polyunsaturated n-3 fatty acids (n-3-D) display several features of the metabolic syndrome, including obesity, liver steatosis, insulin resistance, hypertension, and cardiac hypertrophy. In this study, the heart phospholipid (PL) and triacylglycerol (TG) fatty acid content and pattern were compared between female control rats (C) and n-3-D rats. The sole n-3 fatty acids found in n-3-D rats, C22:5(n-3) and C22:6(n-3), were 10 to 20 times lower than in C. The total fatty acid content of PL was lower in n-3-D rats than C. No ectopic TG accumulation was found in n-3-D rats. In both PL and TG, the C16:0/C16:1(n-7) and C18:0/C18:1(n-9) ratios suggested increased Delta9-desaturase activity in n-3-D rats. The PL C18:2(n-6)/C20:4(n-6) and C20:4(n-6)/C22:4(n-6) ratios were also lower in n-3-D rats than C. Prior intravenous injection of a medium-chain TG:fish oil emulsion to n-3-D rats 60 to 120 minutes before killing augmented the PL content in C22:5(n-3) and C22:6(n-3), minimized the age-related decrease in the PL C18:1(n-9) relative content, and increased the TG C22:4(n-6) content. The alteration of cardiac function in n-3-D rats and its improvement after injection of medium-chain TG:fish oil emulsion coincides with parallel changes in heart lipid fatty acid content and pattern.
authors.affiliation: Laboratory of Experimental Surgery, Brussels Free University, B-1070 Brussels, Belgium.
authors.forename: Laurence
authors.initials: L
authors.lastname: Portois
authors.forename: Sébastien
authors.initials: S
authors.lastname: Peltier
authors.forename: Abdullah
authors.initials: A
authors.lastname: Sener
authors.forename: Willy J
authors.initials: WJ
authors.lastname: Malaisse
authors.forename: Yvon A
authors.initials: YA
authors.lastname: Carpentier
mesh_terms: D000818:Animals; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects / Q000502:physiology; D007275:Injections, Intravenous; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism*; D010743:Phospholipids / Q000032:analysis* / Q000737:chemistry; D011897:Random Allocation; D051381:Rats; D013230:Stearoyl-CoA Desaturase / Q000378:metabolism; D014280:Triglycerides / Q000032:analysis* / Q000737:chemistry
chemical_list: D015525:Fatty Acids, Omega-3; D010743:Phospholipids; D014280:Triglycerides; D013230:Stearoyl-CoA Desaturase